ā Back to Trial
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
Trial Locations
-
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Contact: Deepak Kilari, MD Ā· 414-805-4600 Ā· [email protected] (opens in new tab)

